Blue Latitude Health’s David Cooney and James Atherton
London-headquartered Blue Latitude Health has expanded its creative marketing healthcare consultancy into the US, launching its first overseas office in New York City.
Led by the UK agency’s James Atherton, who becomes managing consultant and US vice president, the new US office will initially offer strategic consultancy services with a view to providing Blue Latitude Health’s full service offering as the branch grows.
Co-founder and managing director at Blue Latitude Health Martin Brass said: “We are very excited to be expanding and opening an office in New York City, where we will be able to service our existing clients better and connect with a wider group of healthcare, life sciences and pharmaceutical companies in the US.
“Our model of ‘strategy through creativity’ is gaining measurable traction with clients making us very confident that our expansion and growth will be supported by quality delivery that continues to exceed our clients’ expectations.”
Blue Latitude Health’s current client list includes AbbVie, Bristol-Myers Squibb, Janssen and Pfizer, among others, and employs its insight, strategy, customer experience and creative services to launch brands and maximise products’ commercial potential on the market.
The agency has won several accounts with global and regional brand and medical teams, delivering projects such as Lilly’s Medical Information Cascade, which won the 2015 PMEA Innovation Award at the end of last year.
Adding to his co-founder’s comments, Fred Bassett, head of strategy at Blue Latitude Health, said: “The opening of our US office marks the achievement of another exciting milestone in BLH’s growth.
“We still feel we’re just scratching the surface of what we’re capable of in terms of the value we can bring to our clients.
“We believe there is a major opportunity for our innovative approach, and with this step into the US, we are demonstrating our commitment to making our business truly global.”